TSE:KSI kneat.com Q3 2024 Earnings Report C$6.16 +0.07 (+1.15%) As of 04/24/2025 04:00 PM Eastern Earnings HistoryForecast kneat.com EPS ResultsActual EPSC$0.01Consensus EPS -C$0.05Beat/MissBeat by +C$0.06One Year Ago EPS-C$0.05kneat.com Revenue ResultsActual RevenueN/AExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/Akneat.com Announcement DetailsQuarterQ3 2024Date11/6/2024TimeAfter Market ClosesConference Call DateThursday, November 7, 2024Conference Call Time9:00AM ETConference Call ResourcesConference Call AudioConference Call TranscriptInterim ReportEarnings HistoryCompany ProfilePowered by kneat.com Q3 2024 Earnings Call TranscriptProvided by QuartrNovember 7, 2024 ShareLink copied to clipboard.There are 9 speakers on the call. Operator00:00:00Good day, and thank you for standing by. Welcome to the Neat Third Quarter 2024 Earnings Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. Please be advised that today's conference is being recorded. Operator00:00:35I would now like to hand the conference over to your first speaker today. Speaker 100:00:48Thank you, operator, and welcome everyone to Neat's Earnings Conference Call for the Q3 of 2024. Today's call will be hosted by Eddie Ryan, Neat's CEO and Hugh Cavanagh, Neat's CFO. Please note the Safe Harbor statement on Slide 2 and the forward looking statements disclosure at the end of the earnings release, informing you that some comments made on today's call contain forward looking information. This information by its nature is subject to risks and uncertainties, so actual results may differ materially from the views expressed today. For further information on these risks and uncertainties, please consult the company's relevant filings, which can be found on SEDAR and on the company's website at neet.com/investors. Speaker 100:01:30Also, during the call, we may refer to certain supplementary financial measures as key performance indicators. Management uses both IFRS measures and supplementary financial measures as key performance indicators in planning, monitoring and evaluating the company's performance. Management believes that these non IFRS measures provide additional insight into the company's financial results, and certain investors may use this information to evaluate the company's performance from period to period. For your reference, we have filed our consolidated financial statements and MD and A on SEDAR, and they are also available on our website. I now pass the call to Eddie Ryan, CEO of Neets. Speaker 200:02:09Thank you, Katie. Good morning, everyone, and thank you for joining the call today. After running through the highlights of the past few months, Hugh and I will open up the call for your questions. We made great strides this past quarter with both revenue and gross profit growth accelerating for the Q2 in a row. Annual recurring revenue grew 59% year over year to $49,900,000 Revenue grew 52% year over year to $12,800,000 Gross profit grew 78% year over year to $9,800,000 while operating expense grew 15% over the same period. Speaker 200:02:48Deal flow in the quarter included the purchase of hundreds of new licenses for use across the Americas, Europe and Asia. The expansion of licenses within existing customers drove our growth as it typically does. The tick up in services revenue in quarter 3 reflects timing of milestones achieved in the quarter. As we grow our partner community, they are increasingly able to provide services such as training, pilots and process mapping. We welcome 2 new partners in quarter 3 to the growing network of businesses eager to take the lead building out and building on needs platform across the ecosystem. Speaker 200:03:28The success we are seeing with our partner program is just one example of the progress we have made this year against our 4 strategic goals, which are to expand within our current customers, gain market share, develop and strengthen the Neat GX platform and keep getting closer to profitability. I'll confess that expanding within our current customers is the easiest of the 4. Since getting validation activities to a high standard of reliability is why customers come to us in the 1st place. The rollout to get all validation process on a single platform is a natural follow through. Expansion within existing customers contributes to our second objective, which is to gain share of the market for e validation software in the life sciences. Speaker 200:04:16But bringing brand new customers into the fold is more important to this goal, given the vast array of highly regulated companies that can benefit from digitizing their validation activities. It's worth noting that our US2 $1,000,000,000 TAM includes thousands of companies, and we ended 2023 with 85 of these. Each new customer adds to our already solid foundation for longer term growth. We brought on several strategic new customers in the past month, and we expect each one of them to expand their use of NEAT well beyond their initial implementation. Our third strategic objective to develop and strengthen the NEAT platform is also a vector for growth. Speaker 200:05:00And improvements that come with each new release have immediate utility. They also serve as stepping stones to our longer term product aspirations, which stretch beyond validation into other areas of quality management. We took a step forward in October with the availability of Neat GX9.3, which among other features enables customers to more easily bring data from legacy systems into Neat. Finally, and just as important as longevity of Neat is our progress towards profitability. Growth in operating expenses slowed in quarter 3, while growth in revenues and gross profit dollars increased, which points us in the right direction. Speaker 200:05:43Given our progress here over the past few quarters, the equity raise we completed last month was an option rather than an obligation and grants us greater flexibility going forward. All in, we're making great headway across the board. None of this, of course, happens without the focus and dedication of the LEAP team day in and day out. Sustaining success takes perseverance, and we're grateful to have a company full of people with this characteristic, whether it's solving hard problems developing the software or doing demos and workshops to a potential customer who wants to be absolutely sure Speaker 300:06:27results. Thank you, Eddie. As I take you through the numbers, please keep in mind that all the numbers I will be discussing are in Canadian dollars unless otherwise noted. Revenue continued to climb in Q3, expanding 52% over last year's Q3 to $12,800,000 SaaS revenue grew 48% year over year to $11,500,000 and ARR grew 59% year over year to $49,900,000 The strong revenue growth in Q3 drove year to date growth higher. It was up 44% to $35,200,000 SaaS revenue accounted for $32,000,000 of this, up 51% versus the 1st 9 months of 2023. Speaker 300:07:19As Eddie mentioned, customers expanding their use of NexGX was the biggest contributor to revenue growth in the quarter. Revenue from new customers that is customers coming on in the past 12 months grew as well. In Q3, professional services grew 90% over last year's Q3, mainly due to the timing of achievement of milestones within various projects. Gross margin continued in the right direction as cost of revenues for the Q3 of 2024 was $3,000,000 up 2% from the cost of revenues in Q3 of 2023. This brings cost of revenue for the 1st 9 months of the year to $8,800,000 up 7% for the same period last year. Speaker 300:08:13Gross profit for the 3 months ended September 30, 2024 was $9,800,000 78 percent higher than $5,500,000 in the Q3 of 2023. Gross margin percentage for Q3 was 77%, its highest level yet. Year to date through Q3 saw gross profit grow 63% to $26,400,000 which represents a gross margin level of 75 percent for the 9 months period. Operating expenses grew 15% in the 3rd quarter to $10,000,000 versus $8,700,000 in Q3 of 2023. Sales and marketing expense was up 26% year over year to $3,900,000 in Q3 versus $3,100,000 in the Q3 of 2023. Speaker 300:09:14R and D expense, net of R and D capitalizations was up 2% year over year to $3,900,000 in the Q3 compared to $3,800,000 in the Q3 of last year. Year to date, operational expenses totaled $31,500,000 18% higher than they were in the comparable prior year period. We ended the quarter with total annual recurring revenue ARR of $49,900,000 up 59% from $31,400,000 at the end of last year's Q3. ARR for SaaS license fees was $49,700,000 also up 59% from $31,300,000 of SaaS ARR at the 30th September 2023. Overall, we are happy with our financial position. Speaker 300:10:13As we shared before the start of this year, our aim was to leverage investment made in years past rather than embark on large new investments. We've done this well as we contemplate our coming investments for our next leg of growth in 2025 beyond. We intend to exercise the same discipline in decision making that we have to date. I will now turn the call over to our operator for your questions. Operator00:10:47Thank you. At this time, we will conduct the question and answer session. Your first question comes from the line of Doug Taylor of Canaccord. Doug, please go ahead. Speaker 400:11:24Thank you, and good morning, everyone or afternoon for some. My first question is on the investment you've made in computer systems validation of CSV, clearly starting to yield some results with the new customer you've announced since quarter end. And I'd just like to ask you what you can tell us about the initiatives you have in place or you're working on to take that CSV solution back into your existing customer base to cross sell? I mean, do you have to wait for an RFP of some of CSV specifically? Or can you sort of creep into that process as well as part of your usual expansion motion? Speaker 400:12:04What does that look like? Speaker 200:12:06Hi, Doug. Thanks for your question. Yes, that's a good question. And so CSV is ongoing right now, and we would say that the value that is beginning to come forward. The one thing to remember is that Neat already has CSV, but we're enhancing the existing solution. Speaker 200:12:23So our customers are using CSV already and they're using our existing solution. And as we bring out and deliver the newer version of CSC over the next file, the customers will transition over time. There isn't a new RFP or anything like that. The customers will continue on with their new validation activities in the newer version, and they can also use the older version and discontinue that over time. Speaker 400:12:51Okay. I appreciate that color. Perhaps a similar question. You talked about the Neat GX 9.3 release having increasing the functionality to transition data from legacy systems into Neat. I mean, is that a feature aimed at your existing customer base to help with expansion process? Speaker 400:13:12Or is that more about reducing the barriers to entry for new customers that you'd like to add to the Knee platform? Speaker 200:13:22Yes. There's multiple reasons for that actually. It's a capability to allow customers to if we're if they have already validation deliverables that they want to store in a safe place and move into their one platform for validation, they can do that very quickly through this capability. So you could be talking about 1,000 and 1,000 of documents, 1,000,000 in fact, and we have the capability to move them into Neath in a very robust performance manner. And there's also a huge amount of documentation that's often transferred in from vendors in the supply chain as part of their deliverables and parts of their handover to the client, the manufacturer. Speaker 200:13:59And they can do that at bulk as well depending on the size and the quantity of them. But that's a really good feature. It's allowing us to transition also out of maybe legacy validation platforms into these also. Speaker 400:14:15Maybe one more for me before I pass the line. I guess this one's probably for Hugh. The gross margin this quarter surprised to the upside despite what was a higher mix of pro service revenue, which is great to see. I mean, I guess the question is, was there any seasonal element around holidays or anything like that in there or one time that you would flag? Or are most of these gains just the result of your ongoing scale improvements and we should take that as indicative of the future margin profile? Speaker 300:14:52Yes. So yes, you have noted that we had a jump in pro services revenue this quarter and that's really reflective of just the timing of the completion of projects, the achievement of milestones and the completion of projects and then the recognition of the revenue for those projects. And I said as I've said on previous calls, I mean, on the cost side, I mean, we recognize the consultancy and growth pro services type costs as they're incurred. So as a result, if there's a quarter where there's either a spike in revenue, that will have a positive impact on margin or if there's a drop because there's less projects completed in a particular quarter, then that would have a slightly down impact on gross margin. So this quarter is certainly, it's we have the revenues higher, so that has certainly helped margins for this quarter. Speaker 400:15:52Okay. Well, congratulations on another strong quarter. I'll pass the line. Operator00:15:57Thanks. Sorry. Excuse me. One moment for your next question. The next question comes from the line of Scott Fletcher of CIBC World Markets. Operator00:16:14Scott, please go ahead. Speaker 500:16:17Hi, good morning. Just wanted to ask a question on the ARR additions in the quarter and what it might mean for Q4. Obviously, really strong strong ARR adds in Q3, well above what you added in Q3 last year. Just wondering if that has anything if any of that was maybe pulled forward from what's typically a strong Q4? Or are you still expecting Q4 to be typically strong in terms of ARR additions? Speaker 200:16:42Yes. So good question, Scott. And yes, so we see that as natural growth for me. I would say we continue and expect to be the strong pipeline for Q4. So we expect to deliver on Q4 also. Speaker 200:16:56This is a result of our customers scaling, more of our customers scaling and adding new logos, new customers as well. So this is what I would expect of a result of good hard work from our sales and marketing team and our product team delivering the capabilities that customers are asking for. Speaker 500:17:18Okay, great. Good to hear. And then just on the expenses and the proceeds from the equity raise, obviously, expenses expense growth is even down sequentially, if you like looking at the operating expense lines. How should we expect that to change going forward, obviously, with the proceeds expected to be invested in some of those OpEx lines? Speaker 200:17:40Yes. So I would say that so we definitely are in the process of evaluating our strategic options regarding the raise and all that. And the raise is there to multiple things, right? But it is also there to allow us to address the opportunity in the marketplace. Our customers telling us where there's value we can add and more things we can do for our customers. Speaker 200:18:02So I think if you look into the year ahead, you're definitely going to see additional spend in the areas of R and D, go to market, customer success and support. You will see additional spending there. Not going to be a step change, but it's going to obviously be there. So you can expect a bit more than that going through 2025. Speaker 500:18:23Okay, thanks. I will pass the line there. Operator00:18:27One moment for your next question. The next question comes from the line of Adir Kaive at 8 Capital. Adir, please go ahead. Speaker 600:18:47Hey, good morning, guys. This is Akiran on for Adiyeh. Congratulations on the quarter. Now for my first, I wanted to circle back on the new medical devices manufacturer customer last week. Can you provide some color as to how the land and expand model works with these customers versus the core life sciences vertical? Speaker 200:19:06Yes. So they're similar to all our strategic customers, right? And they get announceable because they have that run rate in front of them, right. So we see the high probability of being able to scale these to multiple 1,000 of dollars per annum, right. But they'll start out smallish, right, maybe $100,000 $200,000 that type of thing. Speaker 200:19:31And over a couple of years, they'll expand 2 additional licenses. So they have this runway ahead of them, so new processes. So today, they'll add on new validation processes as they go forward, and they'll expand those processes to additional sites across their network. So they're announced because they have that potential. They have a lot of sites and they have a lot of potential users in them. Speaker 200:19:58So we expect them to expand over 3, 4 years to their max from a validation perspective. Speaker 600:20:07Okay. So that based on kind of similar. And then I want to touch on the product crumb for the GX platform. Now GX 9.3 launched last week and comes after 9.2 in April. I mean with upcoming features and well staffed R and D team, how do you see the processes and time to markets with these sprints change? Speaker 600:20:25Thanks. Speaker 200:20:27So I'm not sure I got the full question there, but I think I got it right. So you're saying that we're releasing it more often now. And how does that affect our, I guess, our delivery of features into the marketplace, the speed of delivery? Is that the question? Speaker 600:20:45Correct. Yes. Speaker 200:20:46Yes, exactly. So I mean, that's exactly what it is, right? It's the ability to have, I guess, smaller changes, higher quality software on a regular cadence, getting features to our customers faster as they need them and also being able to get so any urgent updates to them and stuff like that. But key is to get features into the marketplace more frequently. And obviously customers are asking for these features and waiting for those and we want to be able to deliver for them. Speaker 600:21:20Thanks guys. I'll pass the line. Operator00:21:24One moment for your next question. The next question comes from the line of Gavin Fairweather of Cormark. Gavin, please go ahead. Speaker 700:21:39Hey, good morning, good afternoon. Congrats on the strong results. First question for me is kind of zeroing in on your strategic customer cohort. Would it be fair to say that outside of your largest customer, which has an enterprise agreement, the rest of your strategic customers are also expanding nicely? And maybe just secondly, what are you hearing from the customer cohort in terms of 2025 expansion plans? Speaker 200:22:05Hi, Gavin. So yes, it's kind of business as usual. I would say they are all on that journey. And from quarter to quarter different customers are expanding at different rates. Some of those customers are ticking up and looking for enterprise agreements and that type of thing. Speaker 200:22:23So I would say that that cohort of customers are all heading in that expansion journey. From year to year, there will be different customers that will take the lead on the expansion, but they're all heading in that journey and we see the same type of thing playing out with those customers in 2025. Speaker 700:22:41That's great to hear. And then just on the product side, you're clearly positioning to be the one stop shop for validation end to end. So I guess curious what feedback you're getting from customers on your refreshed CSA, CSV offering and what kind of response are you getting from customers as you kind of make that pitch to be really the one stop platform for all of their needs? Speaker 200:23:09Yes, we're getting, I would say, very positive feedback from our customers and they're supporting the process, giving us additional feedback where we can enhance it further as we go. But I would say that, yes, the customers love the ease of use of these and they love the fact that they can set their process up their way on our platform no matter what type of validation activity it is. Like I said earlier on, we already have the CSV capability in the platform, but we believe it's not as good as it could should be and we're enhancing that now. And so it's working really well, Gavin, and the customers love the vision of it and they love what we're delivering. And it will start getting into their use as we go through 2025. Speaker 700:23:52Perfect. And then I know many customers are starting to use the product a bit for processes outside of validation and it's capable of handling a wide array of regulated workflows and capture the data. But curious how far away we are from kind of licenses attached to those adjacencies starting to be maybe a more material growth driver for you. I know that's a focus for the R and D team. Guess I'm just curious when you think that's going to start to be more material in terms of a revenue driver. Speaker 200:24:23Yes. So it is happening, Gavin, you're correct. And it continues with its vision of a platform on which you can create an intelligent data driven regulated process that's really strong on data integrity, easy to use on one platform. And the customers see that very clearly and they're already asking us to do adjacencies right now. And yes, we're hearing them and going through the process with them. Speaker 200:24:44But we're saying guys, we want to continue to give you the best validation platform. We're the leaders in validation right now. We're the gold standard. We want to continue to We're the leaders in validation right now. We're the gold standard. Speaker 200:24:50We want to continue to make that great for you because there's still some things to be done there, such as a more enhanced CSV and the like. So but customers are going there and I can see stuff happening not too far away, Gavin. But I don't want to forecast that right now because I want the company to stay focused on doing what we're great at right now and consolidating our leadership position there. But those adjacencies will open up into course. Speaker 700:25:17Got it. And then lastly for me, maybe for Hugh, just on cost of goods sold. Can you help me understand how you're holding the line? I mean, when you look at the SaaS revenue growth that's coming through, I would have thought that your Speaker 600:25:28hosting costs would be moving quite a bit higher Speaker 300:25:29given the top line Speaker 700:25:29growth and usage of the costs would be moving quite a bit higher given the top line growth and usage of the platform. Maybe you can walk me through that and help me understand what kind of increases in cost of goods sold we should think about going forward? Yes. So I mean cost of goods sold is made up Speaker 300:25:43Yes. So I mean cost of goods sold is made up of the cost of goods sold associated with the different revenue lines. So there's a significant chunk of the cost of goods as you can see associated with the professional services. And I mean, that's obviously holding pretty constant. And then on the license side, I mean, the cost of goods is made up of a few different pieces. Speaker 300:26:09It's the support people who respond to tickets and so on. It's also obviously the hosting costs and then the SaaS team who basically look after customers who live customers on the platform. And so I suppose one thing to bear in mind is that as customers grow, it doesn't necessarily drive headcount because if you want a customer who's on a lot of stuff, a lot of different processes then you're obviously not going to add to customer support headcount in line with that. From a hosting perspective, yes, I mean hosting costs obviously are continuing to creep up all the time associated with things like adding new customers, but also to do with the number of users on the system and also to do with storage and all the rest, the usual sort of drivers of cloud hosting costs. So yes, for sure that piece is increasing as we continue to add customers and add users. Speaker 300:27:20But we're certainly getting some efficiencies of scale associated with customers expanding and so on. And obviously on the PS side and the professional service side then we've had things fairly flat there. Speaker 700:27:38Okay. That's it for me. Thanks so much. Operator00:27:41One moment for your last question. The last question comes from the line of Justin Keywood of Stifel. Justin, please go ahead. Speaker 800:27:57Good morning. Thanks for taking my call. Just wondering if you have an update on the CPG vertical. I know there was a large win around the fall of last year. If you're continuing to see heightened activity and what's your outlook for that vertical? Speaker 200:28:15Hi, Justin. Yes, CPG from a validation perspective is still part of our sweet spot. And we continue to bring them into our pipeline. We continue to harvest them through the pipeline. And we have had a number of those announcements in CPG this year. Speaker 200:28:32So yes, the short answer is still a very important segment, but it's not as big a segment from, say, an expansion perspective. It's there, it's good, but it's not as big as someone like a pharmaceutical company. Speaker 800:28:48And any other verticals that you could be targeting in the short or medium term? I know aerospace was potentially mentioned at one point or are you laser focused on the pharma and perhaps CPG in the near Speaker 200:29:04term? Yes. I would say CPG, I treat them as my life sciences customers because they don't dilute any aspect of our business to deal with them or to secure them or to sign them up, right? So they're part of our life sciences business. So I would we look at our Life Sciences today for validation is a $2,000,000,000 TAM, Justin. Speaker 200:29:21And when we look beyond that, back to what Gavin asked earlier on, we're talking about the adjacencies within Life Sciences. We see that in expanding our TAM to 7,000,000,000 dollars Beyond that, we're talking about what you're mentioning there, which is what can we go to after that. But there's a huge amount to be done here right now and the focus is on that. So we don't have any real exploration done beyond Life Sciences. And Life Sciences today is multiple segments. Speaker 200:29:49It's a big manufacturer, small manufacturer, biotech, etcetera, medical devices, supply chain entities, contract development organizations, contract research organizations, engineering companies, vendor manufacturers of complex equipment. That's what makes up to $2,000,000,000 TAM. And even logistics companies play on both sides of the manufacturing. So also have to comply with regulations. All these companies are subject to good manufacturing practice regulations. Speaker 200:30:16And that's where our sweet spot for us is right now. Speaker 800:30:20Very interesting. Thank you for the context. Speaker 300:30:25Thanks Justin. Operator00:30:27Thank you. That does conclude the question and answer session. I would now like to hand it back to management for closing remarks. Speaker 200:30:40Thank you everyone for your time and attention today and your support for Neet. The speed and extent to which digitization occurs in life sciences makes a positive difference to speed, costs and ultimately quality, which benefits us all. So we're pleased to have your support and we'll do our best to keep earning it. Thank you very much. Operator00:31:04Thank you for your participation in today's conference. This does conclude the program. You may now disconnect. Speaker 300:31:13Okay. I just okay. Okay. Speaker 100:31:23Yeah. Yeah. It just said button said we're still live and there were still people clicking off. So Operator00:31:28Okay. Alright. Speaker 300:31:29Okay. I'm just going to connect with my crowd and say thank you.Read morePowered by Conference Call Audio Live Call not available Earnings Conference Callkneat.com Q3 202400:00 / 00:00Speed:1x1.25x1.5x2x Earnings DocumentsInterim report kneat.com Earnings HeadlinesKSI:CA kneat.com, inc.April 13, 2025 | seekingalpha.comkneat.com: Critical Service SaaS In The High-Growth Pharmaceutical IndustryMarch 25, 2025 | seekingalpha.comTrump to unlock 15-figure fortune for America (May 3rd) ?We were shown this map by former Presidential Advisor, Jim Rickards, one of the most politically connected men in America. Rickards has spent his fifty-year career in the innermost circles of the U.S. government and banking. And he believes Trump could soon release this frozen asset to the public. April 25, 2025 | Paradigm Press (Ad)CIBC Sticks to Their Buy Rating for kneat.com (KSI)March 2, 2025 | markets.businessinsider.comkneat.com, inc.: Kneat Achieves Record Revenue for Fourth Quarter and Full Year 2024February 28, 2025 | finanznachrichten.deInvesting in kneat.com (TSE:KSI) five years ago would have delivered you a 148% gainFebruary 11, 2025 | finance.yahoo.comSee More kneat.com Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like kneat.com? Sign up for Earnings360's daily newsletter to receive timely earnings updates on kneat.com and other key companies, straight to your email. Email Address About kneat.comkneat.com (TSE:KSI) Inc is in the business of developing and marketing a software application for modelling regulated data-intensive processes for regulated industries, focusing on the life sciences industry. The company has developed Kneat Gx solution which provides management real-time visibility and control and increases product, quality, and compliance. In addition, it provides software-related services including training, installation, upgrades, consulting and maintenance.View kneat.com ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Earnings By Country U.S. Earnings Reports Canadian Earnings Reports U.K. Earnings Reports Latest Articles Seismic Shift at Intel: Massive Layoffs Precede Crucial EarningsRocket Lab Lands New Contract, Builds Momentum Ahead of EarningsAmazon's Earnings Could Fuel a Rapid Breakout Tesla Earnings Miss, But Musk Refocuses and Bulls ReactQualcomm’s Range Narrows Ahead of Earnings as Bulls Step InWhy It May Be Time to Buy CrowdStrike Stock Heading Into EarningsCan IBM’s Q1 Earnings Spark a Breakout for the Stock? Upcoming Earnings Cadence Design Systems (4/28/2025)Welltower (4/28/2025)Waste Management (4/28/2025)AstraZeneca (4/29/2025)Booking (4/29/2025)DoorDash (4/29/2025)Honeywell International (4/29/2025)Mondelez International (4/29/2025)PayPal (4/29/2025)Regeneron Pharmaceuticals (4/29/2025) Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
There are 9 speakers on the call. Operator00:00:00Good day, and thank you for standing by. Welcome to the Neat Third Quarter 2024 Earnings Call. At this time, all participants are in a listen only mode. After the speakers' presentation, there will be a question and answer session. Please be advised that today's conference is being recorded. Operator00:00:35I would now like to hand the conference over to your first speaker today. Speaker 100:00:48Thank you, operator, and welcome everyone to Neat's Earnings Conference Call for the Q3 of 2024. Today's call will be hosted by Eddie Ryan, Neat's CEO and Hugh Cavanagh, Neat's CFO. Please note the Safe Harbor statement on Slide 2 and the forward looking statements disclosure at the end of the earnings release, informing you that some comments made on today's call contain forward looking information. This information by its nature is subject to risks and uncertainties, so actual results may differ materially from the views expressed today. For further information on these risks and uncertainties, please consult the company's relevant filings, which can be found on SEDAR and on the company's website at neet.com/investors. Speaker 100:01:30Also, during the call, we may refer to certain supplementary financial measures as key performance indicators. Management uses both IFRS measures and supplementary financial measures as key performance indicators in planning, monitoring and evaluating the company's performance. Management believes that these non IFRS measures provide additional insight into the company's financial results, and certain investors may use this information to evaluate the company's performance from period to period. For your reference, we have filed our consolidated financial statements and MD and A on SEDAR, and they are also available on our website. I now pass the call to Eddie Ryan, CEO of Neets. Speaker 200:02:09Thank you, Katie. Good morning, everyone, and thank you for joining the call today. After running through the highlights of the past few months, Hugh and I will open up the call for your questions. We made great strides this past quarter with both revenue and gross profit growth accelerating for the Q2 in a row. Annual recurring revenue grew 59% year over year to $49,900,000 Revenue grew 52% year over year to $12,800,000 Gross profit grew 78% year over year to $9,800,000 while operating expense grew 15% over the same period. Speaker 200:02:48Deal flow in the quarter included the purchase of hundreds of new licenses for use across the Americas, Europe and Asia. The expansion of licenses within existing customers drove our growth as it typically does. The tick up in services revenue in quarter 3 reflects timing of milestones achieved in the quarter. As we grow our partner community, they are increasingly able to provide services such as training, pilots and process mapping. We welcome 2 new partners in quarter 3 to the growing network of businesses eager to take the lead building out and building on needs platform across the ecosystem. Speaker 200:03:28The success we are seeing with our partner program is just one example of the progress we have made this year against our 4 strategic goals, which are to expand within our current customers, gain market share, develop and strengthen the Neat GX platform and keep getting closer to profitability. I'll confess that expanding within our current customers is the easiest of the 4. Since getting validation activities to a high standard of reliability is why customers come to us in the 1st place. The rollout to get all validation process on a single platform is a natural follow through. Expansion within existing customers contributes to our second objective, which is to gain share of the market for e validation software in the life sciences. Speaker 200:04:16But bringing brand new customers into the fold is more important to this goal, given the vast array of highly regulated companies that can benefit from digitizing their validation activities. It's worth noting that our US2 $1,000,000,000 TAM includes thousands of companies, and we ended 2023 with 85 of these. Each new customer adds to our already solid foundation for longer term growth. We brought on several strategic new customers in the past month, and we expect each one of them to expand their use of NEAT well beyond their initial implementation. Our third strategic objective to develop and strengthen the NEAT platform is also a vector for growth. Speaker 200:05:00And improvements that come with each new release have immediate utility. They also serve as stepping stones to our longer term product aspirations, which stretch beyond validation into other areas of quality management. We took a step forward in October with the availability of Neat GX9.3, which among other features enables customers to more easily bring data from legacy systems into Neat. Finally, and just as important as longevity of Neat is our progress towards profitability. Growth in operating expenses slowed in quarter 3, while growth in revenues and gross profit dollars increased, which points us in the right direction. Speaker 200:05:43Given our progress here over the past few quarters, the equity raise we completed last month was an option rather than an obligation and grants us greater flexibility going forward. All in, we're making great headway across the board. None of this, of course, happens without the focus and dedication of the LEAP team day in and day out. Sustaining success takes perseverance, and we're grateful to have a company full of people with this characteristic, whether it's solving hard problems developing the software or doing demos and workshops to a potential customer who wants to be absolutely sure Speaker 300:06:27results. Thank you, Eddie. As I take you through the numbers, please keep in mind that all the numbers I will be discussing are in Canadian dollars unless otherwise noted. Revenue continued to climb in Q3, expanding 52% over last year's Q3 to $12,800,000 SaaS revenue grew 48% year over year to $11,500,000 and ARR grew 59% year over year to $49,900,000 The strong revenue growth in Q3 drove year to date growth higher. It was up 44% to $35,200,000 SaaS revenue accounted for $32,000,000 of this, up 51% versus the 1st 9 months of 2023. Speaker 300:07:19As Eddie mentioned, customers expanding their use of NexGX was the biggest contributor to revenue growth in the quarter. Revenue from new customers that is customers coming on in the past 12 months grew as well. In Q3, professional services grew 90% over last year's Q3, mainly due to the timing of achievement of milestones within various projects. Gross margin continued in the right direction as cost of revenues for the Q3 of 2024 was $3,000,000 up 2% from the cost of revenues in Q3 of 2023. This brings cost of revenue for the 1st 9 months of the year to $8,800,000 up 7% for the same period last year. Speaker 300:08:13Gross profit for the 3 months ended September 30, 2024 was $9,800,000 78 percent higher than $5,500,000 in the Q3 of 2023. Gross margin percentage for Q3 was 77%, its highest level yet. Year to date through Q3 saw gross profit grow 63% to $26,400,000 which represents a gross margin level of 75 percent for the 9 months period. Operating expenses grew 15% in the 3rd quarter to $10,000,000 versus $8,700,000 in Q3 of 2023. Sales and marketing expense was up 26% year over year to $3,900,000 in Q3 versus $3,100,000 in the Q3 of 2023. Speaker 300:09:14R and D expense, net of R and D capitalizations was up 2% year over year to $3,900,000 in the Q3 compared to $3,800,000 in the Q3 of last year. Year to date, operational expenses totaled $31,500,000 18% higher than they were in the comparable prior year period. We ended the quarter with total annual recurring revenue ARR of $49,900,000 up 59% from $31,400,000 at the end of last year's Q3. ARR for SaaS license fees was $49,700,000 also up 59% from $31,300,000 of SaaS ARR at the 30th September 2023. Overall, we are happy with our financial position. Speaker 300:10:13As we shared before the start of this year, our aim was to leverage investment made in years past rather than embark on large new investments. We've done this well as we contemplate our coming investments for our next leg of growth in 2025 beyond. We intend to exercise the same discipline in decision making that we have to date. I will now turn the call over to our operator for your questions. Operator00:10:47Thank you. At this time, we will conduct the question and answer session. Your first question comes from the line of Doug Taylor of Canaccord. Doug, please go ahead. Speaker 400:11:24Thank you, and good morning, everyone or afternoon for some. My first question is on the investment you've made in computer systems validation of CSV, clearly starting to yield some results with the new customer you've announced since quarter end. And I'd just like to ask you what you can tell us about the initiatives you have in place or you're working on to take that CSV solution back into your existing customer base to cross sell? I mean, do you have to wait for an RFP of some of CSV specifically? Or can you sort of creep into that process as well as part of your usual expansion motion? Speaker 400:12:04What does that look like? Speaker 200:12:06Hi, Doug. Thanks for your question. Yes, that's a good question. And so CSV is ongoing right now, and we would say that the value that is beginning to come forward. The one thing to remember is that Neat already has CSV, but we're enhancing the existing solution. Speaker 200:12:23So our customers are using CSV already and they're using our existing solution. And as we bring out and deliver the newer version of CSC over the next file, the customers will transition over time. There isn't a new RFP or anything like that. The customers will continue on with their new validation activities in the newer version, and they can also use the older version and discontinue that over time. Speaker 400:12:51Okay. I appreciate that color. Perhaps a similar question. You talked about the Neat GX 9.3 release having increasing the functionality to transition data from legacy systems into Neat. I mean, is that a feature aimed at your existing customer base to help with expansion process? Speaker 400:13:12Or is that more about reducing the barriers to entry for new customers that you'd like to add to the Knee platform? Speaker 200:13:22Yes. There's multiple reasons for that actually. It's a capability to allow customers to if we're if they have already validation deliverables that they want to store in a safe place and move into their one platform for validation, they can do that very quickly through this capability. So you could be talking about 1,000 and 1,000 of documents, 1,000,000 in fact, and we have the capability to move them into Neath in a very robust performance manner. And there's also a huge amount of documentation that's often transferred in from vendors in the supply chain as part of their deliverables and parts of their handover to the client, the manufacturer. Speaker 200:13:59And they can do that at bulk as well depending on the size and the quantity of them. But that's a really good feature. It's allowing us to transition also out of maybe legacy validation platforms into these also. Speaker 400:14:15Maybe one more for me before I pass the line. I guess this one's probably for Hugh. The gross margin this quarter surprised to the upside despite what was a higher mix of pro service revenue, which is great to see. I mean, I guess the question is, was there any seasonal element around holidays or anything like that in there or one time that you would flag? Or are most of these gains just the result of your ongoing scale improvements and we should take that as indicative of the future margin profile? Speaker 300:14:52Yes. So yes, you have noted that we had a jump in pro services revenue this quarter and that's really reflective of just the timing of the completion of projects, the achievement of milestones and the completion of projects and then the recognition of the revenue for those projects. And I said as I've said on previous calls, I mean, on the cost side, I mean, we recognize the consultancy and growth pro services type costs as they're incurred. So as a result, if there's a quarter where there's either a spike in revenue, that will have a positive impact on margin or if there's a drop because there's less projects completed in a particular quarter, then that would have a slightly down impact on gross margin. So this quarter is certainly, it's we have the revenues higher, so that has certainly helped margins for this quarter. Speaker 400:15:52Okay. Well, congratulations on another strong quarter. I'll pass the line. Operator00:15:57Thanks. Sorry. Excuse me. One moment for your next question. The next question comes from the line of Scott Fletcher of CIBC World Markets. Operator00:16:14Scott, please go ahead. Speaker 500:16:17Hi, good morning. Just wanted to ask a question on the ARR additions in the quarter and what it might mean for Q4. Obviously, really strong strong ARR adds in Q3, well above what you added in Q3 last year. Just wondering if that has anything if any of that was maybe pulled forward from what's typically a strong Q4? Or are you still expecting Q4 to be typically strong in terms of ARR additions? Speaker 200:16:42Yes. So good question, Scott. And yes, so we see that as natural growth for me. I would say we continue and expect to be the strong pipeline for Q4. So we expect to deliver on Q4 also. Speaker 200:16:56This is a result of our customers scaling, more of our customers scaling and adding new logos, new customers as well. So this is what I would expect of a result of good hard work from our sales and marketing team and our product team delivering the capabilities that customers are asking for. Speaker 500:17:18Okay, great. Good to hear. And then just on the expenses and the proceeds from the equity raise, obviously, expenses expense growth is even down sequentially, if you like looking at the operating expense lines. How should we expect that to change going forward, obviously, with the proceeds expected to be invested in some of those OpEx lines? Speaker 200:17:40Yes. So I would say that so we definitely are in the process of evaluating our strategic options regarding the raise and all that. And the raise is there to multiple things, right? But it is also there to allow us to address the opportunity in the marketplace. Our customers telling us where there's value we can add and more things we can do for our customers. Speaker 200:18:02So I think if you look into the year ahead, you're definitely going to see additional spend in the areas of R and D, go to market, customer success and support. You will see additional spending there. Not going to be a step change, but it's going to obviously be there. So you can expect a bit more than that going through 2025. Speaker 500:18:23Okay, thanks. I will pass the line there. Operator00:18:27One moment for your next question. The next question comes from the line of Adir Kaive at 8 Capital. Adir, please go ahead. Speaker 600:18:47Hey, good morning, guys. This is Akiran on for Adiyeh. Congratulations on the quarter. Now for my first, I wanted to circle back on the new medical devices manufacturer customer last week. Can you provide some color as to how the land and expand model works with these customers versus the core life sciences vertical? Speaker 200:19:06Yes. So they're similar to all our strategic customers, right? And they get announceable because they have that run rate in front of them, right. So we see the high probability of being able to scale these to multiple 1,000 of dollars per annum, right. But they'll start out smallish, right, maybe $100,000 $200,000 that type of thing. Speaker 200:19:31And over a couple of years, they'll expand 2 additional licenses. So they have this runway ahead of them, so new processes. So today, they'll add on new validation processes as they go forward, and they'll expand those processes to additional sites across their network. So they're announced because they have that potential. They have a lot of sites and they have a lot of potential users in them. Speaker 200:19:58So we expect them to expand over 3, 4 years to their max from a validation perspective. Speaker 600:20:07Okay. So that based on kind of similar. And then I want to touch on the product crumb for the GX platform. Now GX 9.3 launched last week and comes after 9.2 in April. I mean with upcoming features and well staffed R and D team, how do you see the processes and time to markets with these sprints change? Speaker 600:20:25Thanks. Speaker 200:20:27So I'm not sure I got the full question there, but I think I got it right. So you're saying that we're releasing it more often now. And how does that affect our, I guess, our delivery of features into the marketplace, the speed of delivery? Is that the question? Speaker 600:20:45Correct. Yes. Speaker 200:20:46Yes, exactly. So I mean, that's exactly what it is, right? It's the ability to have, I guess, smaller changes, higher quality software on a regular cadence, getting features to our customers faster as they need them and also being able to get so any urgent updates to them and stuff like that. But key is to get features into the marketplace more frequently. And obviously customers are asking for these features and waiting for those and we want to be able to deliver for them. Speaker 600:21:20Thanks guys. I'll pass the line. Operator00:21:24One moment for your next question. The next question comes from the line of Gavin Fairweather of Cormark. Gavin, please go ahead. Speaker 700:21:39Hey, good morning, good afternoon. Congrats on the strong results. First question for me is kind of zeroing in on your strategic customer cohort. Would it be fair to say that outside of your largest customer, which has an enterprise agreement, the rest of your strategic customers are also expanding nicely? And maybe just secondly, what are you hearing from the customer cohort in terms of 2025 expansion plans? Speaker 200:22:05Hi, Gavin. So yes, it's kind of business as usual. I would say they are all on that journey. And from quarter to quarter different customers are expanding at different rates. Some of those customers are ticking up and looking for enterprise agreements and that type of thing. Speaker 200:22:23So I would say that that cohort of customers are all heading in that expansion journey. From year to year, there will be different customers that will take the lead on the expansion, but they're all heading in that journey and we see the same type of thing playing out with those customers in 2025. Speaker 700:22:41That's great to hear. And then just on the product side, you're clearly positioning to be the one stop shop for validation end to end. So I guess curious what feedback you're getting from customers on your refreshed CSA, CSV offering and what kind of response are you getting from customers as you kind of make that pitch to be really the one stop platform for all of their needs? Speaker 200:23:09Yes, we're getting, I would say, very positive feedback from our customers and they're supporting the process, giving us additional feedback where we can enhance it further as we go. But I would say that, yes, the customers love the ease of use of these and they love the fact that they can set their process up their way on our platform no matter what type of validation activity it is. Like I said earlier on, we already have the CSV capability in the platform, but we believe it's not as good as it could should be and we're enhancing that now. And so it's working really well, Gavin, and the customers love the vision of it and they love what we're delivering. And it will start getting into their use as we go through 2025. Speaker 700:23:52Perfect. And then I know many customers are starting to use the product a bit for processes outside of validation and it's capable of handling a wide array of regulated workflows and capture the data. But curious how far away we are from kind of licenses attached to those adjacencies starting to be maybe a more material growth driver for you. I know that's a focus for the R and D team. Guess I'm just curious when you think that's going to start to be more material in terms of a revenue driver. Speaker 200:24:23Yes. So it is happening, Gavin, you're correct. And it continues with its vision of a platform on which you can create an intelligent data driven regulated process that's really strong on data integrity, easy to use on one platform. And the customers see that very clearly and they're already asking us to do adjacencies right now. And yes, we're hearing them and going through the process with them. Speaker 200:24:44But we're saying guys, we want to continue to give you the best validation platform. We're the leaders in validation right now. We're the gold standard. We want to continue to We're the leaders in validation right now. We're the gold standard. Speaker 200:24:50We want to continue to make that great for you because there's still some things to be done there, such as a more enhanced CSV and the like. So but customers are going there and I can see stuff happening not too far away, Gavin. But I don't want to forecast that right now because I want the company to stay focused on doing what we're great at right now and consolidating our leadership position there. But those adjacencies will open up into course. Speaker 700:25:17Got it. And then lastly for me, maybe for Hugh, just on cost of goods sold. Can you help me understand how you're holding the line? I mean, when you look at the SaaS revenue growth that's coming through, I would have thought that your Speaker 600:25:28hosting costs would be moving quite a bit higher Speaker 300:25:29given the top line Speaker 700:25:29growth and usage of the costs would be moving quite a bit higher given the top line growth and usage of the platform. Maybe you can walk me through that and help me understand what kind of increases in cost of goods sold we should think about going forward? Yes. So I mean cost of goods sold is made up Speaker 300:25:43Yes. So I mean cost of goods sold is made up of the cost of goods sold associated with the different revenue lines. So there's a significant chunk of the cost of goods as you can see associated with the professional services. And I mean, that's obviously holding pretty constant. And then on the license side, I mean, the cost of goods is made up of a few different pieces. Speaker 300:26:09It's the support people who respond to tickets and so on. It's also obviously the hosting costs and then the SaaS team who basically look after customers who live customers on the platform. And so I suppose one thing to bear in mind is that as customers grow, it doesn't necessarily drive headcount because if you want a customer who's on a lot of stuff, a lot of different processes then you're obviously not going to add to customer support headcount in line with that. From a hosting perspective, yes, I mean hosting costs obviously are continuing to creep up all the time associated with things like adding new customers, but also to do with the number of users on the system and also to do with storage and all the rest, the usual sort of drivers of cloud hosting costs. So yes, for sure that piece is increasing as we continue to add customers and add users. Speaker 300:27:20But we're certainly getting some efficiencies of scale associated with customers expanding and so on. And obviously on the PS side and the professional service side then we've had things fairly flat there. Speaker 700:27:38Okay. That's it for me. Thanks so much. Operator00:27:41One moment for your last question. The last question comes from the line of Justin Keywood of Stifel. Justin, please go ahead. Speaker 800:27:57Good morning. Thanks for taking my call. Just wondering if you have an update on the CPG vertical. I know there was a large win around the fall of last year. If you're continuing to see heightened activity and what's your outlook for that vertical? Speaker 200:28:15Hi, Justin. Yes, CPG from a validation perspective is still part of our sweet spot. And we continue to bring them into our pipeline. We continue to harvest them through the pipeline. And we have had a number of those announcements in CPG this year. Speaker 200:28:32So yes, the short answer is still a very important segment, but it's not as big a segment from, say, an expansion perspective. It's there, it's good, but it's not as big as someone like a pharmaceutical company. Speaker 800:28:48And any other verticals that you could be targeting in the short or medium term? I know aerospace was potentially mentioned at one point or are you laser focused on the pharma and perhaps CPG in the near Speaker 200:29:04term? Yes. I would say CPG, I treat them as my life sciences customers because they don't dilute any aspect of our business to deal with them or to secure them or to sign them up, right? So they're part of our life sciences business. So I would we look at our Life Sciences today for validation is a $2,000,000,000 TAM, Justin. Speaker 200:29:21And when we look beyond that, back to what Gavin asked earlier on, we're talking about the adjacencies within Life Sciences. We see that in expanding our TAM to 7,000,000,000 dollars Beyond that, we're talking about what you're mentioning there, which is what can we go to after that. But there's a huge amount to be done here right now and the focus is on that. So we don't have any real exploration done beyond Life Sciences. And Life Sciences today is multiple segments. Speaker 200:29:49It's a big manufacturer, small manufacturer, biotech, etcetera, medical devices, supply chain entities, contract development organizations, contract research organizations, engineering companies, vendor manufacturers of complex equipment. That's what makes up to $2,000,000,000 TAM. And even logistics companies play on both sides of the manufacturing. So also have to comply with regulations. All these companies are subject to good manufacturing practice regulations. Speaker 200:30:16And that's where our sweet spot for us is right now. Speaker 800:30:20Very interesting. Thank you for the context. Speaker 300:30:25Thanks Justin. Operator00:30:27Thank you. That does conclude the question and answer session. I would now like to hand it back to management for closing remarks. Speaker 200:30:40Thank you everyone for your time and attention today and your support for Neet. The speed and extent to which digitization occurs in life sciences makes a positive difference to speed, costs and ultimately quality, which benefits us all. So we're pleased to have your support and we'll do our best to keep earning it. Thank you very much. Operator00:31:04Thank you for your participation in today's conference. This does conclude the program. You may now disconnect. Speaker 300:31:13Okay. I just okay. Okay. Speaker 100:31:23Yeah. Yeah. It just said button said we're still live and there were still people clicking off. So Operator00:31:28Okay. Alright. Speaker 300:31:29Okay. I'm just going to connect with my crowd and say thank you.Read morePowered by